We offer a team approach, ensuring each of our patients benefit from the coordinated attention of experts in pediatric gastroenterology, hepatology, nutrition, rheumatology, pediatric surgery, ophthalmology, psychology, social work and child life specialists.

Our commitment is to provide individualized care for each patient, alongside education to build the confidence of both the patient and his or her family about their ability to live and thrive with IBD. Our pediatric IBD team is part of the C.S. Mott Children's Hospital Pediatric Gastroenterology team, working alongside other experts needed to provide whole-person care.

Our IBD team includes nurse educators who work with patients and their families to provide support and resources. Our social workers provide support across every aspect of a child’s life, including school adjustment and social issues related to IBD and its symptoms. Our team can refer our patients for psychological support to assist children with adjustment to IBD management and any issues arising from related IBS co-management. We also have a peer mentoring program in which we are able to match patients and families up with peers who have been through similar journeys to provide support. 

As adolescents approach adulthood, we work closely with each patient to prepare them for transitioning their care to adult gastroenterology specialists to ensure seamless continuity of care.

Schedule an appointment by calling us at 734-763-9650.

U-M Health is also home to an Adult Inflammatory Bowel Disease Program.

The C.S. Mott Children’s Hospital IBD team actively participates in research to understand IBD more fully, advance treatment options, and improve outcomes and quality of life for individuals with IBD. 

Areas of pediatric IBD research include the following:

• Quality improvement methods to improve outcomes for pediatric IBD
• Using MRI to improve treatment of pediatric IBD
• Preventing fistula-related complications of Crohn’s disease
• Developing tools to improve communication around risks of medications and risks of disease
• Minimizing steroid use in the treatment of pediatric IBD